Skip to main content
PMC home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1996 Oct;72(5):315–320. doi: 10.1136/sti.72.5.315

Antibiotic treatment of gonorrhoea--clinical evidence for choice.

C Bignell 1
PMCID: PMC1195696  PMID: 8976845

Full text

PDF
319

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong J. H., Zacarias F., Rein M. F. Ophthalmia neonatorum: a chart review. Pediatrics. 1976 Jun;57(6):884–892. [PubMed] [Google Scholar]
  2. Balachandran T., Roberts A. P., Evans B. A., Azadian B. S. Single-dose therapy of anogenital and pharyngeal gonorrhoea with ciprofloxacin. Int J STD AIDS. 1992 Jan-Feb;3(1):49–51. doi: 10.1177/095646249200300112. [DOI] [PubMed] [Google Scholar]
  3. Blankenship R. M., Holmes R. K., Sanford J. P. Treatment of disseminated gonococcal infection. A prospective evaluation of short-term antibiotic therapy. N Engl J Med. 1974 Jan 31;290(5):267–269. doi: 10.1056/NEJM197401312900508. [DOI] [PubMed] [Google Scholar]
  4. Boslego J. W., Tramont E. C., Takafuji E. T., Diniega B. M., Mitchell B. S., Small J. W., Khan W. N., Stein D. C. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med. 1987 Jul 30;317(5):272–278. doi: 10.1056/NEJM198707303170504. [DOI] [PubMed] [Google Scholar]
  5. Brook M. G., Clark S., Stirland A., Kelsey M. C., Paice E. W., Kell P. D., Atia W. A. A case cluster of possible tissue invasive gonorrhoea. Genitourin Med. 1995 Apr;71(2):126–128. doi: 10.1136/sti.71.2.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cavenee M. R., Farris J. R., Spalding T. R., Barnes D. L., Castaneda Y. S., Wendel G. D., Jr Treatment of gonorrhea in pregnancy. Obstet Gynecol. 1993 Jan;81(1):33–38. [PubMed] [Google Scholar]
  7. Echols R. M., Heyd A., O'Keeffe B. J., Schacht P. Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: a worldwide summary. Sex Transm Dis. 1994 Nov-Dec;21(6):345–352. doi: 10.1097/00007435-199411000-00009. [DOI] [PubMed] [Google Scholar]
  8. Faruki H., Kohmescher R. N., McKinney W. P., Sparling P. F. A community-based outbreak of infection with penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). N Engl J Med. 1985 Sep 5;313(10):607–611. doi: 10.1056/NEJM198509053131004. [DOI] [PubMed] [Google Scholar]
  9. Fransen L., Nsanze H., Klauss V., Van der Stuyft P., D'Costa L., Brunham R. C., Piot P. Ophthalmia neonatorum in Nairobi, Kenya: the roles of Neisseria gonorrhoeae and Chlamydia trachomatis. J Infect Dis. 1986 May;153(5):862–869. doi: 10.1093/infdis/153.5.862. [DOI] [PubMed] [Google Scholar]
  10. Goodhart G. L. Treatment of uncomplicated genital gonorrhea. Sex Transm Dis. 1979 Apr-Jun;6(2 Suppl):126–142. doi: 10.1097/00007435-197904000-00018. [DOI] [PubMed] [Google Scholar]
  11. Graudal C., Bollerup A. C., Lange K., Seier K., Lind I. The outcome of single-dose cefuroxime treatment in patients with pharyngeal gonorrhea. Sex Transm Dis. 1985 Jan-Mar;12(1):49–51. doi: 10.1097/00007435-198501000-00010. [DOI] [PubMed] [Google Scholar]
  12. Guinan M. E., Biddle J., Thornsberry C., Reynolds G., Zaidi A., Wiesner P. The National Gonorrhea Therapy Monitoring Study: I. Review of treatment results and of in-vitro antibiotic susceptibility, 1972-1978. Sex Transm Dis. 1979 Apr-Jun;6(2 Suppl):93–102. [PubMed] [Google Scholar]
  13. Haase D. A., Nash R. A., Nsanze H., D'Costa L. J., Fransen L., Piot P., Brunham R. C. Single-dose ceftriaxone therapy of gonococcal ophthalmia neonatorum. Sex Transm Dis. 1986 Jan-Mar;13(1):53–55. doi: 10.1097/00007435-198601000-00012. [DOI] [PubMed] [Google Scholar]
  14. Hallqvist L., Lindgren S. Gonorrhoea of the throat at a venereological clinic. Incidence and Results of Treatment. Br J Vener Dis. 1975 Dec;51(6):395–397. doi: 10.1136/sti.51.6.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Handsfield H. H., Dalu Z. A., Martin D. H., Douglas J. M., Jr, McCarty J. M., Schlossberg D. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group. Sex Transm Dis. 1994 Mar-Apr;21(2):107–111. doi: 10.1097/00007435-199403000-00010. [DOI] [PubMed] [Google Scholar]
  16. Handsfield H. H., McCormack W. M., Hook E. W., 3rd, Douglas J. M., Jr, Covino J. M., Verdon M. S., Reichart C. A., Ehret J. M. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group. N Engl J Med. 1991 Nov 7;325(19):1337–1341. doi: 10.1056/NEJM199111073251903. [DOI] [PubMed] [Google Scholar]
  17. Handsfield H. H., McCutchan J. A., Corey L., Ronald A. R. Evaluation of new anti-infective drugs for the treatment of uncomplicated gonorrhea in adults and adolescents. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992 Nov;15 (Suppl 1):S123–S130. doi: 10.1093/clind/15.supplement_1.s123. [DOI] [PubMed] [Google Scholar]
  18. Handsfield H. H., Wiesner P. J., Holmes K. K. Treatment of the gonococcal arthritis-dermatitis syndrome. Ann Intern Med. 1976 Jun;84(6):661–667. doi: 10.7326/0003-4819-84-6-661. [DOI] [PubMed] [Google Scholar]
  19. Hutt D. M., Judson F. N. Epidemiology and treatment of oropharyngeal gonorrhea. Ann Intern Med. 1986 May;104(5):655–658. doi: 10.7326/0003-4819-104-5-655. [DOI] [PubMed] [Google Scholar]
  20. Issack M. I., French G. L., O'Farrell N. Continuing high prevalence of penicillinase-producing Neisseria gonorrhoeae at a central London hospital. Genitourin Med. 1995 Aug;71(4):265–265. doi: 10.1136/sti.71.4.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jaffe H. W., Biddle J. W., Johnson S. R., Wiesner P. J. Infections due to penicillinase-producing Neisseria gonorrhoeae in the United States: 1976-1980. J Infect Dis. 1981 Aug;144(2):191–197. doi: 10.1093/infdis/144.2.191. [DOI] [PubMed] [Google Scholar]
  22. Judson F. N., Ehret J. M., Handsfield H. H. Comparative study of ceftriaxone and spectinomycin for treatment of pharyngeal and anorectal gonorrhea. JAMA. 1985 Mar 8;253(10):1417–1419. [PubMed] [Google Scholar]
  23. Judson F. N., Rothenberg R. Tetracycline in the treatment of uncomplicated male gonorrhea. J Am Vener Dis Assoc. 1976 Dec;3(2 Pt 1):56–58. [PubMed] [Google Scholar]
  24. Kam K. M., Wong P. W., Cheung M. M., Ho N. K., Lo K. K. Quinolone-resistant Neisseria gonorrhoeae in Hong Kong. Sex Transm Dis. 1996 Mar-Apr;23(2):103–108. doi: 10.1097/00007435-199603000-00003. [DOI] [PubMed] [Google Scholar]
  25. Kaplowitz L. G., Vishniavsky N., Evans T., Vartivarian S., Dalton H., Simpson M., Gruninger R. P. Norfloxacin in the treatment of uncomplicated gonococcal infections. Am J Med. 1987 Jun 26;82(6B):35–39. doi: 10.1016/0002-9343(87)90616-4. [DOI] [PubMed] [Google Scholar]
  26. Katz B. P., Zwickl B. W., Caine V. A., Jones R. B. Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis. 1992 Nov-Dec;19(6):351–354. [PubMed] [Google Scholar]
  27. Korting H. C., Kollmann M. Effective single dose treatment of uncomplicated gonorrhoea. Int J STD AIDS. 1994 Jul-Aug;5(4):239–243. doi: 10.1177/095646249400500402. [DOI] [PubMed] [Google Scholar]
  28. Kraus S. J. Incidence and therapy of gonococcal pharyngitis. Sex Transm Dis. 1979 Apr-Jun;6(2 Suppl):143–147. doi: 10.1097/00007435-197904000-00019. [DOI] [PubMed] [Google Scholar]
  29. Kundu A., Wade A. A., Walzman M. Disseminated infection due to penicillin resistant gonococci--is it still rare? Genitourin Med. 1995 Apr;71(2):133–134. doi: 10.1136/sti.71.2.133-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Laga M., Naamara W., Brunham R. C., D'Costa L. J., Nsanze H., Piot P., Kunimoto D., Ndinya-Achola J. O., Slaney L., Ronald A. R. Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone. N Engl J Med. 1986 Nov 27;315(22):1382–1385. doi: 10.1056/NEJM198611273152203. [DOI] [PubMed] [Google Scholar]
  31. Latif A., Mason P., Marowa E., Paraiwa E., Dhamu F., Tambo J., Gwanzura L., Mapeta D., Jongeling G. Management of gonococcal ophthalmia neonatorum with single-dose kanamycin and ocular irrigation with saline. Sex Transm Dis. 1988 Apr-Jun;15(2):108–109. doi: 10.1097/00007435-198804000-00008. [DOI] [PubMed] [Google Scholar]
  32. Lepage P., Bogaerts J., Kestelyn P., Meheus A. Single-dose cefotaxime intramuscularly cures gonococcal ophthalmia neonatorum. Br J Ophthalmol. 1988 Jul;72(7):518–520. doi: 10.1136/bjo.72.7.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lewis D. A., Ison C. A., Livermore D. M., Chen H. Y., Hooi A. Y., Wisdom A. R. A one-year survey of Neisseria gonorrhoeae isolated from patients attending an east London genitourinary medicine clinic: antibiotic susceptibility patterns and patients' characteristics. Genitourin Med. 1995 Feb;71(1):13–17. doi: 10.1136/sti.71.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Martin D. H., Mroczkowski T. F., Dalu Z. A., McCarty J., Jones R. B., Hopkins S. J., Johnson R. B. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med. 1992 Sep 24;327(13):921–925. doi: 10.1056/NEJM199209243271304. [DOI] [PubMed] [Google Scholar]
  35. Mindel A., Tovey S. J., Timmins D. J., Williams P. Primary and secondary syphilis, 20 years' experience. 2. Clinical features. Genitourin Med. 1989 Jan;65(1):1–3. doi: 10.1136/sti.65.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Moran J. S., Levine W. C. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis. 1995 Apr;20 (Suppl 1):S47–S65. doi: 10.1093/clinids/20.supplement_1.s47. [DOI] [PubMed] [Google Scholar]
  37. Moran J. S. Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important? Sex Transm Dis. 1995 Jan-Feb;22(1):39–47. doi: 10.1097/00007435-199501000-00007. [DOI] [PubMed] [Google Scholar]
  38. Moran J. S., Zenilman J. M. Therapy for gonococcal infections: options in 1989. Rev Infect Dis. 1990 Jul-Aug;12 (Suppl 6):S633–S644. doi: 10.1093/clinids/12.supplement_6.s633. [DOI] [PubMed] [Google Scholar]
  39. O'Hara M. A. Ophthalmia neonatorum. Pediatr Clin North Am. 1993 Aug;40(4):715–725. [PubMed] [Google Scholar]
  40. O'Mahony C., Timmins D. Treatment failure using double dose ciprofloxacin in a case of highly resistant gonorrhoea. Genitourin Med. 1992 Aug;68(4):274–275. doi: 10.1136/sti.68.4.274-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Odegaard K., Gundersen T. Gonococcal pharyngeal infection. Br J Vener Dis. 1973 Aug;49(4):350–352. doi: 10.1136/sti.49.4.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Otubu J. A., Imade G. E., Sagay A. S., Towobola O. A. Resistance of recent Neisseria gonorrhoeae isolates in Nigeria and outcome of single-dose treatment with ciprofloxacin. Infection. 1992 Nov-Dec;20(6):339–341. doi: 10.1007/BF01710680. [DOI] [PubMed] [Google Scholar]
  43. Plourde P. J., Tyndall M., Agoki E., Ombette J., Slaney L. A., D'Costa L. J., Ndinya-Achola J. O., Plummer F. A. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection. J Infect Dis. 1992 Oct;166(4):919–922. doi: 10.1093/infdis/166.4.919. [DOI] [PubMed] [Google Scholar]
  44. Rajakumar M. K., Ngeow Y. F., Khor B. S., Lim K. F. Ofloxacin, a new quinolone for the treatment of gonorrhea. Sex Transm Dis. 1988 Jan-Mar;15(1):25–26. doi: 10.1097/00007435-198801000-00005. [DOI] [PubMed] [Google Scholar]
  45. Rice R. J., Thompson S. E. Treatment of uncomplicated infections due to Neisseria gonorrhoeae. A review of clinical efficacy and in vitro susceptibility studies from 1982 through 1985. JAMA. 1986 Apr 4;255(13):1739–1746. [PubMed] [Google Scholar]
  46. Rompalo A. M., Colletta L., Caine V. A., Linnemeier P., Neumann T., Hook E. W., 3rd, Jones R. B. Efficacy of 250 mg trospectomycin sulfate i.m. vs. 250 mg ceftriaxone i.m. for treatment of uncomplicated gonorrhea. Sex Transm Dis. 1994 Jul-Aug;21(4):213–216. [PubMed] [Google Scholar]
  47. Ross J. D., Moyes A., McMillan A., Young H. Temporal changes in the sensitivity of Neisseria gonorrhoeae to penicillin in Edinburgh, Scotland. Int J STD AIDS. 1995 Mar-Apr;6(2):110–113. doi: 10.1177/095646249500600209. [DOI] [PubMed] [Google Scholar]
  48. Rothenberg R. Ophthalmia neonatorum due to neisseria gonorrhoeae: prevention and treatment. Sex Transm Dis. 1979 Apr-Jun;6(2 Suppl):187–191. doi: 10.1097/00007435-197904000-00027. [DOI] [PubMed] [Google Scholar]
  49. Schwarcz S. K., Zenilman J. M., Schnell D., Knapp J. S., Hook E. W., 3rd, Thompson S., Judson F. N., Holmes K. K. National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA. 1990 Sep 19;264(11):1413–1417. [PubMed] [Google Scholar]
  50. Sherrard J., Barlow D. PPNG at St Thomas' Hospital--a changing provenance. Int J STD AIDS. 1993 Nov-Dec;4(6):330–332. doi: 10.1177/095646249300400605. [DOI] [PubMed] [Google Scholar]
  51. Smith B. L., Mogabgab W. J., Dalu Z. A., Jones R. B., Douglas J. M., Jr, Handsfield H. H., Hook E. W., 3rd, Viner B. L., Shands J. W., Jr, McCormack W. M. Multicenter trial of fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea. Am J Med. 1993 Mar 22;94(3A):81S–84S. [PubMed] [Google Scholar]
  52. Stamm W. E., Hicks C. B., Martin D. H., Leone P., Hook E. W., 3rd, Cooper R. H., Cohen M. S., Batteiger B. E., Workowski K., McCormack W. M. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA. 1995 Aug 16;274(7):545–549. [PubMed] [Google Scholar]
  53. Steingrímsson O., Olafsson J. H., Thórarinsson H., Ryan R. W., Johnson R. B., Tilton R. C. Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis. 1994 Jan-Feb;21(1):43–46. doi: 10.1097/00007435-199401000-00009. [DOI] [PubMed] [Google Scholar]
  54. Thompson S. E., 3rd Treatment of disseminated gonococcal infections. Sex Transm Dis. 1979 Apr-Jun;6(2 Suppl):181–184. doi: 10.1097/00007435-197904000-00025. [DOI] [PubMed] [Google Scholar]
  55. Turner A., Gough K. R., Jephcott A. E., McClean A. N. Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline. Genitourin Med. 1995 Aug;71(4):265–266. doi: 10.1136/sti.71.4.265-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wallin J., Siegel M. S. Pharyngeal neisseria gonorrhoeae: coloniser or pathogen? Br Med J. 1979 Jun 2;1(6176):1462–1463. doi: 10.1136/bmj.1.6176.1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Washington A. E., Browner W. S., Korenbrot C. C. Cost-effectiveness of combined treatment for endocervical gonorrhea. Considering co-infection with Chlamydia trachomatis. JAMA. 1987 Apr 17;257(15):2056–2060. [PubMed] [Google Scholar]
  58. Wiesenfeld H. C., Uhrin M., Dixon B. W., Sweet R. L. Diagnosis of male Chlamydia trachomatis urethritis by polymerase chain reaction. Sex Transm Dis. 1994 Sep-Oct;21(5):268–271. doi: 10.1097/00007435-199409000-00004. [DOI] [PubMed] [Google Scholar]
  59. Young H., Bain S. S. Neisserial colonisation of the pharynx. Br J Vener Dis. 1983 Aug;59(4):228–231. doi: 10.1136/sti.59.4.228. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES